glp-1 agonist cardiovascular outcomes Summary of outcome trials with SGLT-2 inhibitors and GLP-1 receptor agonists were developed

A recent study suggests that the use of GLP-1 receptor agonists was associated with better outcomes compared with the use of DPP-4 inhibitors among patients with type 2 diabetes and advanced-stage chronic kidney disease

While Ozempic itself only comes as an injectable, a pill version of semaglutide called Rybelsus is available

Back Heinrich, G, Gros, P, Lund, PK, et al (1984) 'Pre-Proglucagon Messenger Ribonucleic Acid: Nucleotide and Encoded Amino Acid Sequences of the rat pancreatic complementary deoxyribonucleic acid', Endocrinology , 115/6, 2176-81

Not necessarily

Dulaglutide and semaglutide are prescribed for type 2 diabetes management, and semaglutide [in the form of Wegovy] is also approved for chronic weight management in patients with a BMI 30, or 27 with weight-related comorbidities. Trulicity vs